Similar Search Results

Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products : the case of Sri Lanka's patent law

Fernando, Ruwan - 2023

Apart from the basic statutory definition in section 65 of the Intellectual Property Act of Sri Lanka, there do not appear to be any detailed statutory guidelines or judicial decisions to provide any framework for the assessment of inventive step in Sri Lanka. The current statutory definition is...

Persistent link: https://www.econbiz.de/10014324836

Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU : the need to rebalance

Acquah, Daniel Opoku - 2020

Persistent link: https://www.econbiz.de/10012433529

Designing pro-health competition policies in developing countries

Ido, Vitor Henrique Pinto - 2020

Persistent link: https://www.econbiz.de/10012433548

TRIPS flexibilities on patent enforcement : lessons from some developed countries relating to pharmaceutical patent protection

Sarnoff, Joshua D. - 2020

Persistent link: https://www.econbiz.de/10012433661

Guide for the granting of compulsory licenses and government use of pharmaceutical patents

Correa, Carlos María - 2020

Persistent link: https://www.econbiz.de/10012433977

Compulsory licensing as a remedy against excessive pricing of life-saving medicines

Kianzad, Behrang - 2024

The COVID-19 crisis intensified decade-long debates on the interaction between intellectual property rights (IPRs), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a tried-and-tested method to expand access, particularly...

Persistent link: https://www.econbiz.de/10014541546

Brazilian competition law and access to health in Brazil : exploitative pricing in the pharmaceutical sector

Castro, Bruno Braz de - 2022

This paper aims to analyze the interfaces between Brazilian Competition Law and the issue of access to medicines, with a special focus on abuse of industrial property rights and related exclusionary and exploitative effects. The paper analyzes the case law of Brazilian Administrative Council for...

Persistent link: https://www.econbiz.de/10013365665

TRIPS flexibilities and access to medicines : an evaluation of barriers to employing compulsory licenses for patented pharmaceuticals at the WTO

Wong, Anna S. Y.; Cole, Clarke B.; Kohler, Jillian Clare - 2022

without the patent owner's authorization by issuing a compulsory license (CL). In the pharmaceuticals space, governments have … before patent expiry, increasing the supply and reducing the price of patented pharmaceuticals domestically. This paper … evaluates the three primary barriers to employing compulsory licenses for pharmaceuticals underscored by members during TRIPS …

Persistent link: https://www.econbiz.de/10013469578

Negotiating health and autonomy : data exclusivity, healthcare policies and access to pharmaceutical innovations

Menezes, Henrique Zeferino de; Paranhos, Julia; Torres, … - 2024

This paper analyzes the debate over the international dissemination of data exclusivity as a form of protection for clinical trial data. This is a critical demand for pharmaceutical companies seeking larger market shares and longer periods of monopoly in order to recover investments in research...

Persistent link: https://www.econbiz.de/10014637112

Competition law and access to medicines : lessons from Brazilian regulation and practice

Falcão, Matheus Z.; Gondo, Mariana; Navarrete, Ana Carolina - 2021

Competition law may play an important role in drug pricing control by containing high prices derived from economic violations. Since the use of competition tools is not limited by the TRIPS Agreement or other international binding disciplines, there is ample policy room to explore how countries,...

Persistent link: https://www.econbiz.de/10012793471

1
2
3
4
5
6
7
8
Next
Last